WO2005123761A8 - GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION - Google Patents

GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION

Info

Publication number
WO2005123761A8
WO2005123761A8 PCT/IL2005/000661 IL2005000661W WO2005123761A8 WO 2005123761 A8 WO2005123761 A8 WO 2005123761A8 IL 2005000661 W IL2005000661 W IL 2005000661W WO 2005123761 A8 WO2005123761 A8 WO 2005123761A8
Authority
WO
WIPO (PCT)
Prior art keywords
analogs
backbone cyclized
gnrh analogs
metal complexation
gnrh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2005/000661
Other languages
French (fr)
Other versions
WO2005123761A1 (en
Inventor
Chaim Gilon
Yaniv Barda
Eyal Mishani
Nassi Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of WO2005123761A1 publication Critical patent/WO2005123761A1/en
Publication of WO2005123761A8 publication Critical patent/WO2005123761A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides novel diagnostic and therapeutic peptides, specifically GnRH analogs backbone cyclized though metal complexation. The backbone cyclized peptide analogs disclosed possess unique and superior properties over other analogs, such as chemical and metabolic stability, increased bioavailability and improved pharmacokinetics. Pharmaceutical compositions comprising the backbone cyclized GnRH analogs and radiolabelled analogs, kits and reagents for synthesizing same, and methods using such compositions for diagnostic and therapeutic purposes are also disclosed.
PCT/IL2005/000661 2004-06-21 2005-06-21 GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION Ceased WO2005123761A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58072504P 2004-06-21 2004-06-21
US60/580,725 2004-06-21

Publications (2)

Publication Number Publication Date
WO2005123761A1 WO2005123761A1 (en) 2005-12-29
WO2005123761A8 true WO2005123761A8 (en) 2006-02-23

Family

ID=34979792

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2005/000661 Ceased WO2005123761A1 (en) 2004-06-21 2005-06-21 GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION

Country Status (1)

Country Link
WO (1) WO2005123761A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5753206A (en) * 1995-06-07 1998-05-19 Immunomedics, Inc. Radiometal-binding analogues of luteinizing hormone releasing hormone
JP3647881B2 (en) * 1996-07-12 2005-05-18 イムノメディクス，インコーポレイテッド Analogue compounds of radioactive metal element binding peptides
WO2001002022A1 (en) * 1999-05-19 2001-01-11 The Curators Of The University Of Missouri New melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
IL162604A0 (en) * 2002-01-03 2005-11-20 Yissum Res Dev Co Conformationally constrained c-backbone cyclic peptides
IL150384A0 (en) * 2002-06-24 2002-12-01 Peptor Ltd Radiolabelled somatostatin analogs backbone cyclized through metal complexation

Also Published As

Publication number Publication date
WO2005123761A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
WO2004103390A3 (en) Stable analogs of peptide and polypeptide therapeutics
WO2007076032A3 (en) Compositions and methods for producing a composition
WO2004101606A3 (en) Novel peptides that bind to the erythropoietin receptor
WO2009067686A8 (en) Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
IL188475A0 (en) Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors
WO2007149542A3 (en) Antimicrobial kinocidin compositions and methods of use
WO2005118620A3 (en) Methods for preparing internally constraied peptides and peptidomimetics
EP2338333A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
WO2006028429A3 (en) Peptides for targeting the prostate specific membrane antigen
WO2002078693A3 (en) N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
WO2006023627A8 (en) Rapamycin polymorph ii and uses thereof
WO2004024757A3 (en) Modified pna molecules
EP2154157A3 (en) FC region variants
WO2006062685A3 (en) Novel peptides that bind to the erythropoietin receptor
WO2004010929A3 (en) METHODS FOR IMPROVEMENT OF LUNG FUNCTION USING TGF-β INHIBITORS
WO2005076744A3 (en) Method for the preparation of peptide-oligonucleotide conjugates
SE0300119D0 (en) Novel compounds
WO2009080764A3 (en) Oral or nasal administration of compounds comprising amino acid sequences
WO2001047959A3 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
WO2001068705A3 (en) Il-17 receptor like molecules and uses thereof
WO2004082629A3 (en) Novel cyclosporins
WO2004076614A3 (en) Human nucleic acid sequences obtained from prostatic carcinomas
WO2005042717A3 (en) Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
EP1265073A3 (en) Methods for determining plasma free drug concentration
WO2005123761A8 (en) GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 52/2005 UNDER (71) REPLACE "YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM" BY "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM"

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase